Effect of Roxadustat and Erythropoietin on Glycated Hemoglobin of Non-Dialysis Type 2 Diabetic Nephropathy Anemia Patients
<b>Objectives</b>: To investigate the effects of Roxadustat and recombinant human erythropoietin (rHuEPO) on glycemic control and glycated hemoglobin (HbA1c) in non-dialysis type 2 diabetic kidney disease (DKD) patients with anemia. <b>Methods</b>: This retrospective study enrolled 449 patients, who...
Gardado en:
| Principais autores: | , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
MDPI AG
2026-04-01
|
| Series: | Biomedicines |
| Assuntos: | |
| Acceso en liña: | https://www.mdpi.com/2227-9059/14/4/845 |
| Tags: |
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|